These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 7821724)

  • 1. Implantable insulin pumps and metabolic control.
    Hepp KD
    Diabetologia; 1994 Sep; 37 Suppl 2():S108-11. PubMed ID: 7821724
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fasting and postprandial plasma glucose and peripheral insulin levels in insulin-dependent diabetes mellitus and non-insulin-dependent diabetes mellitus subjects during continuous intraperitoneal versus subcutaneous insulin delivery.
    Hermans MP; van Ypersele de Strihou M; Ketelslegers JM; Squifflet JP; Buysschaert M
    Transplant Proc; 1995 Dec; 27(6):3329-30. PubMed ID: 8539974
    [No Abstract]   [Full Text] [Related]  

  • 3. French multicentre experience of implantable insulin pumps. The EVADIAC Study Group. Evaluation of Active Implants in Diabetes Society.
    Broussolle C; Jeandidier N; Hanaire-Broutin H
    Lancet; 1994 Feb; 343(8896):514-5. PubMed ID: 7906761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [From external to implantable insulin pump, can we close the loop?].
    Renard E; Costalat G; Bringer J
    Diabetes Metab; 2002 Sep; 28(4 Pt 2):2S19-2S25. PubMed ID: 12442060
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of dual-hormone artificial pancreas, single-hormone artificial pancreas, and conventional insulin pump therapy for glycaemic control in patients with type 1 diabetes: an open-label randomised controlled crossover trial.
    Haidar A; Legault L; Messier V; Mitre TM; Leroux C; Rabasa-Lhoret R
    Lancet Diabetes Endocrinol; 2015 Jan; 3(1):17-26. PubMed ID: 25434967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Why intraperitoneal delivery of insulin with implantable pumps in NIDDM?
    Duckworth WC; Saudek CD; Henry RR
    Diabetes; 1992 Jun; 41(6):657-61. PubMed ID: 1587393
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current status and future of implantable insulin pumps for the treatment of diabetes.
    Catargi B
    Expert Rev Med Devices; 2004 Nov; 1(2):181-5. PubMed ID: 16293038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Long term safety and efficacy of intraperitoneal insulin infusion by means of implantable pumps.
    Pinget M; Jeandidier N
    Horm Metab Res; 1998 Aug; 30(8):475-86. PubMed ID: 9761375
    [No Abstract]   [Full Text] [Related]  

  • 9. [Intraperitoneal insulin therapy. High tech for treatment of type 1 diabetes].
    Liebl A
    MMW Fortschr Med; 2000 May; 142(21):52-4. PubMed ID: 10872295
    [No Abstract]   [Full Text] [Related]  

  • 10. The management of severe brittle diabetes with "Infusaid" implantable pumps.
    Gill GV; Husband DJ; Wright PD; Sharpe G; Taylor R; Walford S; Marshall SM; Alberti KG
    Diabetes Res; 1986 Mar; 3(3):135-7. PubMed ID: 3709039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SHBG (sex hormone binding globulin) levels in insulin dependent diabetic patients according to the route of insulin administration.
    Lassmann-Vague V; Raccah D; Pugeat M; Bautrant D; Belicar P; Vague P
    Horm Metab Res; 1994 Sep; 26(9):436-7. PubMed ID: 7835829
    [No Abstract]   [Full Text] [Related]  

  • 12. Report of a 7 year case-control study of continuous intraperitoneal insulin infusion and subcutaneous insulin therapy among patients with poorly controlled type 1 diabetes mellitus: favourable effects on hypoglycaemic episodes.
    van Dijk PR; Logtenberg SJ; Groenier KH; Gans RO; Bilo HJ; Kleefstra N
    Diabetes Res Clin Pract; 2014 Nov; 106(2):256-63. PubMed ID: 25305134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Experience with long-term peritoneal insulin infusion from external pumps.
    Selam JL; Slingeneyer A; Saeidi S; Mirouze J; Richard JL; Rodier M; Daynes B; Lapinski H
    Diabet Med; 1985 Jan; 2(1):41-4. PubMed ID: 2951065
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Implanted constant basal rate insulin infusion devices for Type 1 (insulin-dependent) diabetic patients.
    Kritz H; Hagmüller G; Lovett R; Irsigler K
    Diabetologia; 1983 Aug; 25(2):78-81. PubMed ID: 6628877
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beneficial effect of glycaemic improvement in non-ischaemic forms of diabetic retinopathy: a 3-year follow-up.
    Selam JL; Millet P; Zaluski S; Saeidi S; Mirouze J
    Diabet Med; 1986 Jan; 3(1):60-4. PubMed ID: 2951139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Free insulin levels and metabolic effects of meal-time bolus and square-wave intraperitoneal insulin infusion in insulin-dependent diabetic patients.
    Jimenez JT; Walford S; Home PD; Hanning I; Alberti KG
    Diabetologia; 1985 Oct; 28(10):728-33. PubMed ID: 3905470
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin pumps--still a research tool?
    Lauritzen T; Pramming S
    Ann Clin Res; 1984; 16(2):98-106. PubMed ID: 6380393
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of intensive diabetes therapy on the development and progression of neuropathy. The Diabetes Control and Complications Trial Research Group.
    Ann Intern Med; 1995 Apr; 122(8):561-8. PubMed ID: 7887548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implementation of treatment protocols in the Diabetes Control and Complications Trial.
    Diabetes Care; 1995 Mar; 18(3):361-76. PubMed ID: 7555480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term intraperitoneal insulin delivery.
    Pitt HA; Saudek CD; Zacur HA
    Ann Surg; 1992 Oct; 216(4):483-91; discussion 491-2. PubMed ID: 1417197
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.